Skip to main content
Log in

Immunological studies in patients with central nervous system tumors

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Impairment of cell-mediated immunity in patients with primary central nervous system (CNS) tumors has repeatedly been reported but data to demonstrate the undelying immunological defect are not univocal. This report concerns a series of 31 patients harboring a glioma in which we studied:

  1. 1)

    peripheral blood Tlymphocyte subpopulations by monoclonal antibody analysis;

  2. 2)

    cellular responsiveness to mitogens

  3. 3)

    serum immunoglobulin values.

The same parameters were also evaluated in 7 cases of intracranial meningioma and in 8 patients affected by non-proliferative, non-inflammatory CNS diseases. Thirty age-matched healthy volunteers formed the control group.

Neither impairment of Tcells as regard to number, responsiveness and subsets, nor abnormal Ig values were found in these groups. However two patients, harboring respectively a third ventricle low grade astrocytoma and an anterior callosal glioblastoma, presented a striking Tcells impairment. These findings might suggest a correlation between hypothalamus and immune system, as already postulated by several previous experimental and clinical studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mahaley MS, Brooks WH, Roszman TL, Daniel DB, Andka C, Richardson S: Immunobiology of primary intracranial tumors, part I: studies of cellular and humoral general immunocompetence of brain tumor patients. J Neurosurg 46:467–476, 1977

    Google Scholar 

  2. Brooks WH, Roszman TL, Rogers AS: Impairment of rosette forming T -lymphocytes in patients with primary intracranial tumors. Cancer 37:1869–1873, 1976

    Google Scholar 

  3. Brooks WH, Roszman TL, Mahaley MS, Woosley RE: Immunobiology of primary intracranial tumors: II. Analysis of lymphocyte subpopulations in patients with primary brain tumors. Clin Exp Immunol 29:61–66, 1977

    Google Scholar 

  4. Brooks WH, Netsky MG, Horwitz DA, Normansell DE: Cell-mediated immunity in patients with primary brain tumors. J Exp Med 136:1631–1639, 1972

    Google Scholar 

  5. Braun DP, Penn RD, Flannery AM, Harris JE: Immunoregulatory cell-function in peripheral blood leukocytes of patients with intracranial gliomas. Neurosurgery 10:203–205, 1982

    Google Scholar 

  6. Gerosa M, Semenzato G, Amadori G, Olivi A, Rotilio A, Tuccarello M, Iraci G: Long term immunological investigation of malignant intracranial gliomas. Surg Neurol 16:48–52, 1981

    Google Scholar 

  7. Roszman TL, Brooks WH: Immunobiology of primary intracranial tumors -IIII. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumors. Clin Exp Immunol 39:395–401, 1980

    Google Scholar 

  8. Elliott LH, Brooks WH, Roszman TL: Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors. J Immunol 132:1208–1215, 1984

    Google Scholar 

  9. Wahlstrom T. Sensitivity to normal brain antigens of blood lymphocytes from patients with gliomas. Acta Pathol Microbiol Scand 81B:763–767, 1973

    Google Scholar 

  10. Young HF, Sakalas R, Kaplan AM: Inhibition of cell-mediated immunity in patients with brain tumors. Surg Neurol 5:19–23, 1976

    Google Scholar 

  11. Fontana A, Kristensen F, Dubs R, Gemsa D, Weber E: Production of prostaglandin E and an interleukin-l-like factor by cultured astrocytes and C6 glioma cells. J Immunol 129:2413–2419, 1982

    Google Scholar 

  12. Fontana A, Hengartner H, de Tribolet N, Weber E: Glioblastoma cells release interleukin 1 and factors inhibiting Interleukin 2-mediated effects. J Immunol 132:1837–1844, 1984

    Google Scholar 

  13. Lauro GM, Di Lorenzo N, Grossi M, Maleci A, Guidetti B: Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells. Acta Neuropathol 69:278–282, 1986

    Google Scholar 

  14. Gerosa MA, Olivi A, Rosemblum MC, Semenzato GP, Pezzutto A: Impaired immunocompetence in patients with malignant gliomas: the possible role of Tg-lymphocyte subpopulations. Neurosurgery 10:571–573, 1982

    Google Scholar 

  15. Roszman TL, Brooks WH, Elliot CH: Immunobiology of primary intracranial tumors. IV. Suppressor cell function and lectin-binding lymphocyte subpopulations in patients with cerebral tumors. Cancer 50:1273–1279, 1982

    Google Scholar 

  16. Reinherz EL, Kung PG, Goldstein G: Separation of functional subsets of human T -cells by a monoclonal antibody. Proc Nat Acad Sci USA 76:4061–4065, 1979

    Google Scholar 

  17. Krill MP, Apuzzo MLJ: Observation in the study of T-lymphocyte subsets by monoclonal antibodies and flow cytometric analysis in intracranial neoplastic disorders. Clin Neurosurg 30:125–136, 1983

    Google Scholar 

  18. Jondal M, Holm G, Wigzell H: Surface markers on human T and B-lymphocytes. I. A large population of lymphocytes forming non-immune rosettes with sheep red blood cells. J Exp Med 136:207–215, 1972

    Google Scholar 

  19. Leung DYM, Rhodes AR, Geha RV: Enumeration of T-cell subsets in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol 67:450–455, 1981

    Google Scholar 

  20. Businco L, Pandolfi F, Rossi P, Quinti I, Aiuti F: Selective defect of a T -helper subpopulation in severe Immunocombined Immunodeficiency. J Clin Immunol 1:125–130, 1981

    Google Scholar 

  21. Apuzzo ML, Mitchell MS: Immunological aspects of intrinsec glial tumors. J Neurosurg 55:1–18, 1981

    Google Scholar 

  22. Reinherz EL, Moretta L, Roper M, Breard JM, Mingari MC, Cooper MD, Schlossman SF: Human T-lymphocyte subpopulations defined by Fc-receptors and monoclonal antibodies. J Exp Med 151:969–974, 1980

    Google Scholar 

  23. Servadei F, Parente R, Bucci M, Beltrandi E, Tognetti F, Gaist G: Particular features of cell-mediated immunity in patients with anaplastic gliomas. J Neuro Oncol I:327–332, 1983

    Google Scholar 

  24. Wood GW, Morantz RA: Depressed T -lymphocyte function in brain tumor patients: monocytes as suppressor cells. J Neuro Oncol 1:87–94, 1983

    Google Scholar 

  25. Larsson I, Landstrom LE, Larner E, Lundgren E, Miorner M, Strannegard O: Interferon production in glia and glioma cell lines. Infect Immun 22:786–789, 1978

    Google Scholar 

  26. Cross RJ, Markesbury WR, Brooks WH, Roszman TL: Hypothalamic immune interaction -I. The acute effects of anterior hypothalamic lesions on the immune response. Brain Rev 196:79–87, 1980

    Google Scholar 

  27. Saxena QB, Saxena RK, Adler WH: Regulation of NK activity in vitro. Int Archs Allergy Suppl Immun 67:169–174, 1982

    Google Scholar 

  28. Forni G, Bindoni M, Santoni A, Belluardo N, Marchese AE, Giovanelli M: Radiofrequency destruction of the tuberoinfundibolar region of the hypothalamus permanently abrogates NK cell activity in mice. Nature 306:286–290, 1983

    Google Scholar 

  29. Gupta S, Fikrig SM, Noval MS: Immunological studies in patients with isolated growth hormone deficiency. Clin Exp Immunol 54:87–90, 1983

    Google Scholar 

  30. Roszman TL, Jackson JC, Cross RJ, Titus MJ, Markesbery WR, Brooks WH: Neuroanatomic and neurotransmitter influences on immune function. J Immunol 135:769s–772s, 1985

    Google Scholar 

  31. Brooks WH, Caldwell HD, Mortara RH: Immune Responses in Patients with Gliomas. Surg Neurol 2:419–423, 1974

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palmas, L., Moschese, V., Galli, E. et al. Immunological studies in patients with central nervous system tumors. J Neuro-Oncol 5, 29–35 (1987). https://doi.org/10.1007/BF00162762

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00162762

Keywords

Navigation